Shaw J H, Holdaway C M, Humberstone D A
University Department of Surgery, Auckland Hospital, New Zealand.
Surgery. 1988 May;103(5):520-5.
We performed a series of isotopic studies on the role of alpha- or beta-adrenergic activity in the regulation of glucose and protein metabolism in a group of surgical patients receiving total parenteral nutrition. We quantitated rates of glucose turnover and net protein breakdown by the primed constant infusion of 3H-glucose and 14C-urea, respectively. Basal measurements were first performed, and then the effect of either alpha- or beta-adrenergic blockade was assessed by means of the constant infusion of either phentolamine or propranolol. In addition, we assessed the effect of beta-stimulation by infusing the beta-agonist, salbutamol. The institution of alpha-adrenergic blockade did not significantly alter either the plasma glucose level or the rate of glucose production. However, the rate of net protein catabolism decreased significantly after alpha-adrenergic blockade. Before alpha-blockade the value for NPC was 0.88 +/- 0.27 gm/kg/day, and after alpha-blockade the corresponding value was 0.73 +/- 0.24 gm/kg/day (p less than 0.01). beta-Adrenergic blockade resulted in a decrease in the rate of glucose appearance from 38.2 +/- 6.1 mumol/kg/min to 35.1 +/- 5.7 mumol/kg/min, and the plasma glucose clearance increased from 5.0 +/- 0.8 ml/kg/min to 5.4 +/- 0.8 ml/kg/min. As a result of these changes the plasma glucose concentration decreased significantly (p less than 0.01) from 7.4 +/- 0.3 mumol/ml to 6.5 +/- 0.5 mumol/ml. beta-Adrenergic blockade did not significantly decrease the rate of net protein catabolism. beta-Stimulation with salbutamol resulted in a significant increase (p less than 0.05) in the rate of glucose production from 31.3 +/- 4.2 mumol/kg/min to 38.0 +/- 6.5 mumol/kg/min, and as a result the plasma glucose level increased significantly from 6.7 +/- 0.6 mumol/ml to 7.4 +/- 0.6 mumol/ml (p less than 0.04). We conclude from these studies that the role of the adrenergic nervous system in the promotion of endogenous glucose turnover in surgical patients receiving total parenteral nutrition is primarily a beta-adrenergic effect, whereas the promotion of protein catabolism is mainly an alpha-adrenergic effect.
我们对一组接受全胃肠外营养的外科患者,进行了一系列关于α或β肾上腺素能活性在葡萄糖和蛋白质代谢调节中作用的同位素研究。我们分别通过静脉注射3H标记的葡萄糖和14C标记的尿素,来测定葡萄糖周转率和净蛋白质分解率。首先进行基础测量,然后通过持续静脉注射酚妥拉明或普萘洛尔来评估α或β肾上腺素能阻断的效果。此外,我们通过静脉注射β激动剂沙丁胺醇来评估β刺激的效果。α肾上腺素能阻断的实施并未显著改变血糖水平或葡萄糖生成率。然而,α肾上腺素能阻断后净蛋白质分解代谢率显著降低。在α阻断前,NPC值为0.88±0.27克/千克/天,α阻断后相应值为0.73±0.24克/千克/天(p<0.01)。β肾上腺素能阻断导致葡萄糖出现率从38.2±6.1微摩尔/千克/分钟降至35.1±5.7微摩尔/千克/分钟,血浆葡萄糖清除率从5.0±0.8毫升/千克/分钟增至5.4±0.8毫升/千克/分钟。由于这些变化,血糖浓度从7.4±0.3微摩尔/毫升显著降至6.5±0.5微摩尔/毫升(p<0.01)。β肾上腺素能阻断并未显著降低净蛋白质分解代谢率。用沙丁胺醇进行β刺激导致葡萄糖生成率从31.3±4.2微摩尔/千克/分钟显著增至38.0±6.5微摩尔/千克/分钟,结果血糖水平从6.7±0.6微摩尔/毫升显著增至7.4±0.6微摩尔/毫升(p<0.04)。我们从这些研究中得出结论,在接受全胃肠外营养的外科患者中,肾上腺素能神经系统在促进内源性葡萄糖周转方面的作用主要是β肾上腺素能效应,而促进蛋白质分解代谢主要是α肾上腺素能效应。